Back to search
X-linked Hypophosphatemia (XLH)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which X-linked Hypophosphatemia (XLH) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which X-linked Hypophosphatemia (XLH) trials you may qualify forA first-in-human study of KK8123 in adults with X-linked hypophosphatemia.
X-linked hypophosphataemia (XLH) is a rare, hereditary condition. The genetic defect leads to low blood phosphate levels and vitamin D suppression. Phosphate is…
This is an international, multicentre, prospective, non-interventional, observational Registry of patients with X-Linked hypophosphatemia (XLH). The main object…
The goal of this National Registry is to is to collect information from patients with rare kidney diseases, so that it that can be used for research. The purpo…
Children and adults with XLH recruited will be treated with calcitriol alone (without phosphate supplementation) for one year, during which the calcitriol dose…
The objectives of this observational study are to characterize XLH disease presentation and progression and to assess long-term effectiveness and safety of buro…
Through observation of patients with X-linked hypophosphatemic rickets/osteomalacia (XLH) for up to 10 years, the study intends to collect data that allow achie…